ATR Mechanism and Prevention

This version of the course is no longer available.
Need multiple seats for your university or lab? Get a quote
The page below is a sample from the LabCE course . Access the complete course and earn ASCLS P.A.C.E.-approved continuing education credits by subscribing online.

Learn more about (online CE course)
ATR Mechanism and Prevention

It has been demonstrated that certain patients are more prone to ATRs, suggesting that certain donor factors play a role. Like TRALI, it has been suggested that ATRs are most likely to be a two-hit mechanism in which the recipient becomes primed or sensitized prior to transfusion.
Except for the prophylactic use of IgA-deficient donors and plasma reduction for recipients with high-titer class-specific anti-IgA, prevention of ATRs has been limited to pretreatment with antihistamines or steroids. Fortunately with the exception of the anti-IgA related anaphylaxis, most allergic reactions are mild and do not have serious clinical sequelae. They do however result in significant discomfort, cost (for serologic workup), and product wastage.